Krishna Kannan, PhD

VP - Operations & Product at Telesis Bio

Speaker

Dr. Krishna Kannan is the VP - Operations & Product at Telesis Bio. He received his PhD from the University of Illinois at Chicago. He is a long-time associate of Dr. Dan Gibson– the creator of the Gibson assembly® method and has worked closely with other Synthetic Biology pioneers at the J Craig Venture Institute and Viridos (formerly Synthetic Genomics), contributing to the development of the first synthetic cell with a minimal genome and the digital-to-biological converter. Dr. Kannan is widely published in leading peer-reviewed publications such as Cell, Science and Nature Biotechnology. Most recently he has been instrumental in synthetic biology workflow innovations at Telesis Bio including the first de novo full-length construction of the SARS-CoV-2 genome and the novel digital sequence-to-mRNA synthesis automation workflow. Dr. Kannan’s team has also been critically involved in the introduction of the next-generation of Telesis Bio’s automated synthetic biology workstation, the BioXp 9600.